Public list Pharma Startups (4743):
ArBlast is ArBlast was established in December 2005. Using the collagen sheet obtained by processing the human amniotic membrane, it is a regenerative medicine venture that regenerates various tissues.
Company (Alive / Active)
|Investor||Investor Type||Location||Participating Rounds|
|Franklin, Tennessee, United States||Acquired||BioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Company's lead technologies are for the healing and restoration of bone and other tissues. Its lead products are based on recombinant human platelet-derived growth factor BB (rhPDGF-BB). In March 2013, BioMimetic Therapeutics was acquired by Wright Medical Group. The valuation of BioMimetic Therapeuti...Show all||Login to see details|
|Hampton, New Jersey, United States||Acquired||Ikaria is a critical care company focused on developing and commercializing therapies designed to address the significant needs of critically ill patients. The company's product, INOMAX (Inhaled Nitric Oxide) is a vasodilator which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks) neonates.||Login to see details|